Market Currents
Amgen (AMGN) agrees to buy 95.6% of privately-held Turkish company Mustafa Nevzat...
-
Wednesday, April 25, 2012, 8:14 AM ETAmgen (AMGN) agrees to buy 95.6% of privately-held Turkish company Mustafa Nevzat Pharmaceuticals for an amount that values the firm at $700M. The acquisition will help AMGN expand its operations in the fast-growing Turkish market and surrounding region (also: earnings). AMGN +1.3% premarket.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
